Breaking News

Phillips-Medisize Expands Clinical Mfg. Capabilities

The facility is designed to support late stage development of medium- and high-volume products and processes under GMP

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Phillips-Medisize, a Molex company, is expanding its current Global Innovation and Development (GID) site in Struer, Denmark with a dedicated manufacturing development and clinical build unit, which is scheduled to open 2Q20.  Phillips-Medisize provides a range of custom drug delivery devices, connected health solutions and manufacturing services worldwide.    The Phillips-Medisize manufacturing facility will be equipped to serve clients with set up for cleanroom assembly and molding (e.g. for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters